Analyst Ratings for [LMAT] LeMaitre Vascular, Inc.

8/6/25	Upgrades	Mkt Perform Outperform	X
LMAT Lemaitre Vascular Barrington Research
$95
2/28/25	Downgrades	Outperform Mkt Perform	X
LMAT Lemaitre Vascular Barrington Research
2/28/25	Downgrades	Outperform Perform	X
LMAT Lemaitre Vascular Oppenheimer
2/13/25	Initiated	Equal Weight	X
LMAT Lemaitre Vascular Wells Fargo
$95
10/15/24	Initiated	Neutral	X
LMAT Lemaitre Vascular Cantor Fitzgerald
$96
5/31/24	Resumed	Buy	X
LMAT Lemaitre Vascular ROTH MKM
$100
4/26/24	Upgrades	Hold Buy	X
LMAT Lemaitre Vascular Stifel
$59 $75
2/6/24	Resumed	Sector Weight	X
LMAT Lemaitre Vascular KeyBanc Capital Markets
10/23/23	Initiated	Mkt Outperform	X
LMAT Lemaitre Vascular JMP Securities
$60
9/6/23	Initiated	Outperform	X
LMAT Lemaitre Vascular Oppenheimer
$70
8/3/23	Downgrades	Buy Hold	X
LMAT Lemaitre Vascular Jefferies
$63 $67
5/3/23	Upgrades	Mkt Perform Outperform	X
LMAT Lemaitre Vascular Barrington Research
$62
10/28/22	Downgrades	Outperform Mkt Perform	X
LMAT Lemaitre Vascular Barrington Research
2/12/21	Initiated	Sector Weight	X
LMAT Lemaitre Vascular KeyBanc Capital Markets
7/25/19	Reiterated	Outperform	X
LMAT Lemaitre Vascular Barrington Research
$32 $37
7/25/19	Upgrades	Neutral Outperform	X
LMAT Lemaitre Vascular First Analysis Sec
$29 $37
10/8/18	Upgrades	Mkt Perform Outperform	X
LMAT Lemaitre Vascular Barrington Research
$34
10/8/18	Upgrades	Neutral Buy	X
LMAT Lemaitre Vascular ROTH Capital
6/8/18	Resumed	Buy	X
LMAT Lemaitre Vascular ROTH Capital
$38
4/26/18	Downgrades	Buy Hold	X
LMAT Lemaitre Vascular Stifel
$40 $34
4/26/18	Upgrades	Hold Buy	X
LMAT Lemaitre Vascular The Benchmark Company
$40

LMAT LeMaitre Vascular, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.